Newborn genome screening could save lives, but key questions remain unanswered

Large-scale genomic newborn screening studies are being conducted around the world, with the potential to detect genetic diseases early and save lives. However, scientists continue to raise unresolved questions about the scalability, feasibility and net benefit of making such screening universal. The debate centres on whether and how to implement these programmes on a broad public-health scale.